Decode competitor intent before the market makes it obvious.
Competitive advantage is rarely visible from market share alone. We examine where competitors invest, which customers and applications they pursue, how portfolios evolve, what partnerships they form, how they differentiate and where capability gaps may create an opening.

What we analyse
- Competitor landscape and strategic grouping
- Company, portfolio and capability profiling
- Product / service benchmarking
- Market positioning and value proposition analysis
- Partnership, acquisition and investment tracking
- Geographic and customer-segment focus
- Channel and route-to-market assessment
- Strengths, vulnerabilities and strategic whitespace
Questions this work helps answer
- What does a launch, acquisition, capacity expansion or partnership signal?
- Which capability does it add?
- Which customer need does it address?
- Where should we respond, defend or exploit whitespace?
How we create decision value
We distinguish activity from significance and translate competitor moves into strategic intent, implications and response options.

Typical outputs
- Competitor dossiers
- Battlecards
- Benchmark scorecards
- Strategic-move trackers
- Positioning maps
- Whitespace analysis
- Response scenarios
Delivered across our industries
Every engagement is staffed by analysts who have worked inside the sector they are covering.
Pharmaceuticals
Therapeutic areas, access, pricing and tender dynamics
View coverage →Medical Devices
Diagnostics, implants, imaging and connected care
View coverage →Petrochemicals
Feedstock economics, downstream margins and derivatives
View coverage →Oil & Gas
Upstream, midstream and the energy transition
View coverage →See the competitive landscape differently →
Tell us what you need to understand, decide or validate. We will use it to determine the right research approach and the level of depth required.
